Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
4.1%
% of VHT's 417 holdings also in PPH
66.7%
% of PPH's 27 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.3% | 12.1% | 10.3% |
|
ABBVIE INC | 4.7% | 6.1% | 4.7% |
|
JOHNSON & JOHNSON | 4.5% | 6.6% | 4.5% |
|
MERCK & CO. INC. | 3.9% | 4.9% | 3.9% |
|
PFIZER INC | 2.4% | 4.3% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to PPH
|
UNITEDHEALTH GROUP INC | 9.0% |
|
ABBOTT LABORATORIES | 3.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.2% |
|
INTUITIVE SURGICAL INC | 3.1% |
|
DANAHER CORP | 2.6% |
|
AMGEN INC | 2.4% |
|
STRYKER CORP | 2.2% |
|
BOSTON SCIENTIFIC CORP | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 1.9% |
|
GILEAD SCIENCES INC | 1.8% |
VHT Underweight Relative to PPH
 |
NOVO-NORDISK A/S-SPONS ADR | -7.9% |
 |
NOVARTIS AG-ADR | -4.9% |
|
MCKESSON CORP | -4.7% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.5% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.4% |
|
AMERISOURCEBERGEN CORP | -4.4% |
 |
SANOFI-AVENTIS-ADR | -4.1% |
|
BRISTOL-MYERS SQUIBB CO | -4.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.8% |
 |
TEVA PHARMACEUTICAL-SP ADR | -3.6% |